BUY Nippon Life India Asset Management Ltd — Rajesh Palviya, Axis Securities
Nippon Life India Asset Management share price target & all analyst calls
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))6 May 2026via CNBC Awaaz.
Entry₹1,090Inferred
Stop loss₹555-49.08% risk
At expiry₹1,08319 May 2026, 3:30 pm
Expired-0.64%
Follow Rajesh Palviya for new calls(27% target hit, 178 closed calls)Get alertsWatch NAM-INDIA for new buy/sell callsGet alertsSee 1 active Swing call on NAM-INDIASee 149 active Swing picks this week
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
0 supporting1 neutral0 opposing
Supports the BUY call (0)
Nothing found in this tip’s window yet.
Neutral / worth noting (1)
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Nippon Life India Asset Management
- SELL — Sachin Janardan Sarvade, IDBI Capital Markets and Securities23 Oct 2026 · ~2 weeks · target ₹800 · Active
- BUY — Elara Capital23 Oct 2026 · ~1 year · target ₹1,165 · Active
- BUY — Siddharth Rai Mangala16 Oct 2026 · Same day · target ₹1,125 · SL hit
- SELL — Ashish Bahety, Profitmart Securities7 Oct 2026 · ~2 weeks · target ₹1,000 · SL hit
- SELL — Gaurav Sharma, Globe Capital Market30 Sept 2026 · ~2 weeks · target ₹1,000 · Expired
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

